The global “biomarkers” market is set to gain traction from their increasing usage in a wide variety of
applications, namely, drug discovery and development, safety assessment, and medicine. Besides, numerous
biotech and pharmaceutical companies are persistently investing huge sums in the research and development
activities. The increasing prevalence of cancer is also one of the crucial factors that would affect the market
positively during the forecast period.
The above information is given by Fortune Business Insights™ in a r ecent study, titled, “Biomarkers Market
Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User
(Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty
Clinics, and Others), and Regional Forecast, 2019-2026.” The study further mentions that the biomarker
market size was USD 39.10 billion in 2018 and is projected to reach USD 97.51 billion by 2026, thereby
exhibiting a CAGR of 12.1% during the forecast period.
Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/biomarkers-market-102173
Key Players Operating in The Biomarkers MarketInclude:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing
competition frequent innovations are taking place in the market. Some of the companies operating the
industry are:
• Abbott
• R&D System
• F. Hoffmann-La Roche Ltd.
• R&D System
• Thermo Fisher Scientific
• Axon Medchem
• Bio-Rad Laboratories, Inc.
• BioVision Inc.
• Sino Biological Inc.
• CENTOGENE N.V.
• Other key market players
Highlights of the Report:
• In-depth analysis of various insights, namely, Biomarkers Markettrends, growth drivers, opportunities,
and other related challenges.
• Comprehensive details of key market players, their core competencies, and Biomarkers Marketshare.
• The potency of suppliers and buyers to make better business decisions.
• Lists out the market size in terms of volume.
Increasing Demand for Personalized Medicine to Accelerate Growth
Biomarkers are increasingly used in disease diagnostics. They also play an important role in development of
personalized medicine for several disease conditions. Disease diagnosis and treatment procedures possess
certain limitations and because of this, the concept of personalized medicine is becoming popular nowadays.
Patients suffering from immunological disorders and cancer are rapidly inclining towards customized
treatment options based on their genetic and clinical features. It would propel the biomarkers market growth
during the forecast period.
For more information in the analysis of this report, visit:
https://www.fortunebusinessinsights.com/biomarkers-market-102173
